1. Home
  2. OVBC vs TTRX Comparison

OVBC vs TTRX Comparison

Compare OVBC & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

HOLD

Current Price

$43.07

Market Cap

208.5M

Sector

Finance

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$7.02

Market Cap

174.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVBC
TTRX
Founded
1872
2015
Country
United States
United States
Employees
N/A
2
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.5M
174.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
OVBC
TTRX
Price
$43.07
$7.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
39.5K
40.4K
Earning Date
04-28-2026
05-31-2026
Dividend Yield
2.22%
N/A
EPS Growth
42.67
N/A
EPS
0.91
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$46.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.61
$2.57
52 Week High
$51.25
$7.39

Technical Indicators

Market Signals
Indicator
OVBC
TTRX
Relative Strength Index (RSI) 36.80 66.53
Support Level $39.07 $3.92
Resistance Level $45.64 N/A
Average True Range (ATR) 2.17 0.60
MACD -0.63 0.05
Stochastic Oscillator 13.55 85.29

Price Performance

Historical Comparison
OVBC
TTRX

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: